GGrantIndex
← Leaderboards

Nirbhay Kumar

Johns Hopkins University

$12,253,206
Attributed
$15,751,717
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,751,717 · 12

By mechanism

R01$10,319,565 · 5
T32$2,309,326 · 1
D43$1,429,738 · 1
R56$809,760 · 1
R21$808,078 · 2
R03$75,250 · 1

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Malaria

Research focus

MalariaPlasmodium FalciparumPlasmodiumBaseVaccine DevelopmentTransmission ProcessParasitesCulicidaeVaccinesInfectionIn VivoMacaca MulattaProteinsTrainingEvaluationCommunitiesErythrocytesIn VitroFutureImmunogenicityAntigensAreaFeedingAntigen Targeting

Grant awards (50)

mRNA-LNP vaccines targeting multiple stages and multiple species of human malaria parasite$813,160
R01 · FY2025 · AI · contact PI
Combination Vaccines to Interrupt Malaria Transmission$542,919
R01 · FY2020 · AI · contact PI
Combination Vaccines to Interrupt Malaria Transmission$527,067
R01 · FY2019 · AI · contact PI
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$478,775
R01 · FY2019 · AI
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$519,745
R01 · FY2018 · AI
Combination Vaccines to Interrupt Malaria Transmission$357,713
R01 · FY2018 · AI · contact PI
Combination Vaccines to Interrupt Malaria Transmission$175,614
R01 · FY2018 · AI · contact PI
Combination Vaccines to Interrupt Malaria Transmission$581,896
R01 · FY2017 · AI · contact PI
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$478,290
R01 · FY2017 · AI
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$430,682
R01 · FY2016 · AI
Identification of Transmission blocking epitopes on P. vivax 48/45 protein$75,250
R03 · FY2016 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$424,613
T32 · FY2014 · AI
Rational Approach to Optimize Immune Potency of DNA Vaccines$188,125
R21 · FY2014 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$507,302
T32 · FY2013 · AI
Rational Approach to Optimize Immune Potency of DNA Vaccines$205,085
R21 · FY2013 · AI · contact PI
Malaria Vaccine Adjuvant Immunogenicity and Safety$178,911
R21 · FY2013 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$499,422
T32 · FY2012 · AI
Malaria Vaccine Adjuvant Immunogenicity and Safety$235,957
R21 · FY2012 · AI · contact PI
Malaria Training and Research Capacity Building in Southern Africa$142,865
D43 · FY2012 · TW · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$450,573
T32 · FY2011 · AI
A DNA Vaccine to Prevent Transmission of Human Malaria$323,576
R01 · FY2011 · AI · contact PI
Malaria Training and Research Capacity Building in Southern Africa$142,865
D43 · FY2011 · TW · contact PI
A DNA Vaccine to Prevent Transmission of Human Malaria$428,151
R01 · FY2010 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$427,416
T32 · FY2010 · AI
A DNA vaccine to prevent transmission of human malaria$318,804
R01 · FY2010 · AI · contact PI
Malaria Training and Research Capacity Building in Southern Africa$142,864
D43 · FY2010 · TW · contact PI
A DNA Vaccine to Prevent Transmission of Human Malaria$479,503
R01 · FY2009 · AI · contact PI
Plasmodium Recombination of Machinery$404,880
R56 · FY2009 · AI · contact PI
Malaria Training and Research Capacity Building in Southern Africa$142,864
D43 · FY2009 · TW · contact PI
Plasmodium Recombination of Machinery$404,880
R56 · FY2008 · AI · contact PI
A DNA Vaccine to Prevent Transmission of Human Malaria$388,975
R01 · FY2008 · AI · contact PI
Malaria Training and Research Capacity Building in Southern Africa$142,864
D43 · FY2008 · TW · contact PI
A DNA Vaccine to Prevent Transmission of Human Malaria$395,352
R01 · FY2007 · AI · contact PI
MOLECULAR DISSECTION OF P. FALCIPARUM SEXUAL DEVELOPMENT$374,226
R01 · FY2004 · AI
MALARIA RESEARCH AND TRAINING PROGRAM IN ZIMBABWE$142,474
D43 · FY2004 · TW
MOLECULAR DISSECTION OF P. FALCIPARUM SEXUAL DEVELOPMENT$363,325
R01 · FY2003 · AI
A DNA VACCINE TO PREVENT TRANSMISSION OF HUMAN MALARIA$301,600
R01 · FY2003 · AI
MALARIA RESEARCH AND TRAINING PROGRAM IN ZIMBABWE$144,751
D43 · FY2003 · TW
MOLECULAR DISSECTION OF P. FALCIPARUM SEXUAL DEVELOPMENT$352,741
R01 · FY2002 · AI
A DNA VACCINE TO PREVENT TRANSMISSION OF HUMAN MALARIA$349,448
R01 · FY2002 · AI
MALARIA RESEARCH AND TRAINING PROGRAM IN ZIMBABWE$154,133
D43 · FY2002 · TW
PHLEBOTOMY OF NORMAL VOLUNTEERS FOR P FALCIPARUM CULTURE$0
M01 · FY2002 · RR
MOLECULAR DISSECTION OF P. FALCIPARUM SEXUAL DEVELOPMENT$349,903
R01 · FY2001 · AI
A DNA VACCINE TO PREVENT TRANSMISSION OF HUMAN MALARIA$307,300
R01 · FY2001 · AI
MALARIA RESEARCH AND TRAINING PROGRAM IN ZIMBABWE$149,998
D43 · FY2001 · TW
PHLEBOTOMY OF NORMAL VOLUNTEERS FOR P FALCIPARUM CULTURE$0
M01 · FY2001 · RR
MOLECULAR DISSECTION OF P. FALCIPARUM SEXUAL DEVELOPMENT$366,950
R01 · FY2000 · AI
A DNA VACCINE TO PREVENT TRANSMISSION OF HUMAN MALARIA$313,850
R01 · FY2000 · AI
MALARIA RESEARCH AND TRAINING PROGRAM IN ZIMBABWE$124,060
D43 · FY2000 · TW
PHLEBOTOMY OF NORMAL VOLUNTEERS FOR P FALCIPARUM CULTURE$0
M01 · FY2000 · RR